Life Sciences Alternative Funding provides capital to commercial-stage life sciences companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 12, 2015
Harrow Health
|
Post-IPO Debt | $15M | Biotechnology | — |
Mar 10, 2015
Veniti
|
Debt Financing | — | Biotechnology | Yes |
Apr 29, 2014
Integrated Diagnostics
|
Debt Financing | $17M | Biotechnology | — |
Sep 17, 2013
VisionCare Ophthalmic Technologies
|
Debt Financing | $15M | Health Care | — |
Life Sciences Alternative Funding has had 3 exits. Life Sciences Alternative Funding most notable exits include Veniti , Integrated Diagnostics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Aug 8, 2018 | Veniti | M&A | Biotechnology | Detail |
Jul 9, 2018 | Integrated Diagnostics | M&A | Biotechnology | Detail |
Apr 30, 2007 | Harrow Health | IPO | Biotechnology | Detail |